Clinical trial

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant…

NCT00492661 · Janssen-Cilag Pty Ltd, Industry · Completed

Key facts

NCT number NCT00492661
Title A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus
Official title A Pilot Trial of the Effect of Dietary and Exercise Intervention on Insulin Resistance and Metabolic Parameters in De Novo Renal Transplant Recipients on Prograf (Tacrolimus)
Acronym PRIDE
Lead sponsor Janssen-Cilag Pty Ltd, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Renal Transplantion, Kidney Transplantion
Intervention type Drug
Interventions Tacrolimus With Diet and Exercise Intervention
Enrollment 55
Start date Jul 1, 2007
Primary completion Jun 1, 2010
Completion Jun 1, 2010
First posted Jun 27, 2007
Last update posted May 27, 2013
Countries Australia

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies